Prescription medicines require a prescription prepared by a person authorized to prescribe medicine. A prescription medicine is dispensed by a pharmacist, and the prescription medicine typically comes with an information leaflet providing information about the medicine, its side effects, if any, instructions for use of the medicine, and any relevant cautions and warnings.
Most prescription medicines are dispensed by a pharmacist in a bottle or in a blister pack. Some prescription medicines that are dispensed in this manner have complicated instructions for use and may not be easy for a patient to remember. For example, some prescription medicines are to be taken in the morning, afternoon, or evening, some with or without food, some with or without certain types of food, and particular quantities. In these situations, a patient may need to read the bottle or refer back to the information leaflet for instructions when taking the medicine. A patient also may need to keep a log of when he or she took the medicine to ensure compliance with any timing instructions.
The present invention relates to a system and a container for securing and dispensing medicine that provides instructions for use that are visible upon access to and administration of the medicine. In particular, the invention relates to a container, which secures medicine and is child-resistant thereby preventing children from accessing the medicine enclosed within the container. The invention also relates to a method for assembling the child-resistant container. The invention also relates to a method for accessing or dispensing, by an intended user, the medicine secured within the child-resistant container.
Medication packaging is regulated by the government in an effort to ensure that the packaging is substantially child-resistant. Each medication package is constructed to meet specific criteria that are based on the contents within the package and the type and potency of the medication.
In one embodiment, the invention provides a child-resistant medication container assembly. The assembly comprises a blister pack including a plurality of compartments, each of the plurality of compartments configured to support at least one medication; a puck including a recess having a plurality of openings with each opening in the puck corresponding to one of the plurality of compartments of the blister pack; and a box including a first wall opposite a second wall, a plurality of openings extending through the first wall, each of the openings in the first wall being aligned with corresponding perforations in the second wall, each of the openings in the first wall being aligned with one of the openings in the puck and a corresponding compartment of the blister pack.
In another embodiment the invention provides a method of assembling a child-resistant medication container. The method comprises aligning a blister pack including a plurality of compartments with a puck including a recess and a plurality of openings, each of the plurality of openings configured to be complementary to one of the plurality of compartments; attaching the blister pack to the puck; inserting the blister pack and the puck into a box, the box including a first wall opposite a second wall, a plurality of openings extending through the first wall and being aligned with a plurality of perforations in the second wall, each of the aligned plurality of openings and perforations being complementary to one of the plurality of compartments; and closing the box to enclose the blister pack and the puck.
In another embodiment the invention provides a method of dispensing medication secured within a child-resistant medication container to a user. The method comprises providing a container including a box, a puck, and a blister pack, the puck being secured to the box, and the blister pack being secured to the puck; applying a force to at least one compartment of a plurality of compartments of the blister pack, each of the plurality of compartments being aligned with a complementary one of a plurality of openings in a first wall of the box; breaking a seal of the at least one compartment to move medication contained within the at least one compartment; expelling the medication through an opening in the recess of the puck, the opening being complementary to the at least one compartment; and expelling the medication through a perforation in a second wall of the box, the perforation being complementary to the at least one compartment.
Other aspects of the invention will become apparent by consideration of the detailed description and accompanying drawings.
Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways.
FIGS. 1 and 2A-C illustrate a container assembly or package 10 for medication according to a first embodiment of the invention. The medication may be acquired by prescription or available over-the-counter. The container assembly 10 includes a blister pack 20, a puck 100, and a box 150.
As illustrated in
The seals 54 are created by a vacuum in order to enclose the medication 42 within the compartments 40. In the illustrated embodiments, the seals 54 and the compartments 40 enclose the medications 42 such that each of the doses of medication 40 is surrounded and protected by a surrounding air pocket. The air pocket protects the integrity of the dose of medication 40 (e.g., protects the medication from being crushed or prematurely expiring). The foil layer 36 includes one or more perforations or indentations to provide a point where an intended user may push the dose of medication 40 through the foil layer 36 in order to free the medication from the blister pack 20. Alternative or additional embodiments may include blister packs constructed from any suitable material(s) (e.g., cardboard, foam, etc.). Similarly, the compartments may be sealed using suitable alternative methods or materials.
As illustrated in
As noted above with respect to FIGS. 1 and 2A-C, the container assembly 10 includes the puck or template 100. The puck 100 is configured to be complementary to the compartments 40 of the blister pack 20. The puck 100 is a protective device or spacer component that provides a buffer between the blister pack 20 and the box 150. More particularly, the puck 100 provides rigidity to the finished box, deterring children from bending and breaking the perforations on the box around the medication while providing bite protection for the blister pack 20.
With continued reference to
With continued reference to
With continued reference to
The walls 108b, 108b′ include a ribbed surface 130b at the outer ends of the walls. The ribbed surface 130b provides a larger surface area for application of glue or other bonding material(s) for securing the puck 100b to the box 150. The puck 100b can comprise plastic, and be manufactured using an injection molding process, however, other suitable materials or combinations of materials may also be utilized for the puck 100b.
The first portion includes a plurality of openings 532 positioned within the bottom wall 512. The second portion includes a plurality of openings 532′ positioned within the top wall 524 and substantially aligned with the openings 532. An area 536 around each of the plurality of openings 532′ is scalloped where a portion of the top wall 524 is gradually removed with less material being removed as the area transitions from the opening 532′ and moving outwardly. The blister pack 20a is positioned between the first portion 504 and the second portion 508 and the compartments aligned with the openings 532, 532′ before inserting the puck 100c into the box 150.
The puck 100d includes a plurality of individual compartments 562 formed by a first layer of material 564 and a second layer of material 566. The individual compartments 562 support the medication, and the first and second layers of material are secured to the base 540. After the medication and compartments 562 are secured to the base 540, the puck 100d is inserted into the box 150.
The pucks 100, 100a-g of
The pucks 100, 100a-g illustrated and described herein are merely exemplary. Pucks having additional configurations and features are within the scope and spirit of the invention. Therefore, it should be understood that the configuration of the plurality of openings may be adapted to any unique configuration of blister pack. Additionally, body portion, walls, and recess may have any suitable shape or size or dimension. Furthermore, the illustrated pucks may be formed from a composite material including paper pulp and bamboo fiber. The pulp/fiber combination is advantageous because it is environmentally safe and recyclable. However, other materials may be used to form the puck.
As noted above with respect to FIGS. 1 and 2A-C, the medicine container assembly 10 includes the box 150. With reference to
With additional reference to FIGS. 1 and 3-4, the box 150 includes a plurality of walls that together define a cavity 154 therein. Specifically, the box 150 includes a first wall 158 spaced apart from and opposite a second wall 162. The first and second walls 158, 162 are spaced apart by intermediate walls 166. The first wall 158 includes a first side, which faces the cavity 154, and a second side, which faces an exterior of the box 150. The first wall 158 includes a plurality of openings 170 extending between the first and second sides and a protrusion 174 (
FIGS. 33-37A,B illustrate a method of assembling the medication container assembly 10. In particular, the blister pack 20 and one of the pucks 100, 100a-g are configured to be received and secured within the box 150. The cavity 154 receives and secures the puck 100, 100a-g and blister pack 20 therein.
The following description is specific to pucks 100, 100a, 100b, however concepts are similar for pucks 100c-g where similar parts/components are noted but may have different numerals.
The blister pack 20 is coupled to the puck 100, 100a, 100b such that each of the plurality of compartments 40 is aligned with and protrudes through the corresponding plurality of openings 116 into the recess 112 of the puck 100. Glue may be applied to the blister pack to adhere the blister pack to the body 104, 104a, 104b of the puck 100, 100a, 100b. With the puck 100b, glue or other bonding material(s) is applied to the ribbed surfaces 130b at the ends of the walls 108b′ to secure the puck 100b to the corresponding side walls of the box 150.
When secured within the cavity 154 of the box 150, the plurality of compartments 40 and plurality of openings 116, 116a, 116b in the puck 100, 100a, 100b are aligned with the plurality of openings 170 in the first wall 158 and plurality of perforations 178 in the second wall 162. As such, the medication 42 within the cavity 154 is viewable through the plurality of openings 170 in the first wall 158. Within the cavity 154, a gap (not shown) is created between the compartments 40 and the first wall 158 such that the compartments 40 are recessed relative to the first wall 158. Furthermore, the support knobs or ribs 50 of the blister pack 20 are not aligned with corresponding openings or perforations in the first and second walls. As such, the support knobs and ribs 50 maintain the gap or distance as medications 42 are expelled from the compartments 40 and the once medicine-filled compartments 40 are no longer able to retain their shape. A force applied through the plurality of openings 170 in the first wall to one or more of the compartments 40 causes the medication 42 to puncture the seal 54 in the blister pack 20 and severs the perforations 178 from the second wall 162. As such, the medication contained within one or more of the compartments 40 is expelled through the respective opening 116 in the puck 100 thereby creating holes in the second wall 162 of the box (
A third wall or overlay 182 is hingedly coupled to the first wall 158 and/or one of the intermediate walls 166. The third wall 182 includes a first side, which includes medication information, and a second side. The first side of the third wall 182 includes an opening or recessed portion 186 that includes an adhesive configured to couple or removably adhered to the first wall 158. The third wall 182 includes a securement tab or seal 190 (
The box 150 may also include printed portions that provide instructions for administration of the medication contained therein. For example, in the embodiments illustrated and described herein, the box 150 may include regions or sections 194, 194′ that correspond to regions in the blister pack 20. As such, a first region 194 of the box 150 may correspond to a first region (i.e., the first and second regions 60, 60′ in
The medicine container assembly 10 includes several features that prevent a child from accessing the medication contained therein. First, at least the first wall 158 preferably includes a film overlay or laminate, which makes it more difficult for a child to tear or rip the container 10 at or near the openings 170. Additionally, the walls include a glue or other suitable adhesive that effectively couples the walls together, thus preventing a child from easily accessing the interior contents of the container 10. Further, the securement tab 190 is preferably a tamper-evident indicator tab. That is, releasing the securement tab 190 from the intermediate wall changes 166 the color (i.e., by removing a layer of paint or material or the like) of first and second indicator tabs 200. The color of the indicator tabs 200, which is different from the color of the surrounding wall 166, indicates to the user that the securement tab 190 has been initially removed. The securement tab 190 and indicator tabs 200 are advantageous because they alert the user that someone else has already tried to access the medication secured within the container 10. This feature is particularly advantageous to alert parents that a child may have had access to the medication. Another child-resistant feature of the container 10 is that once the third wall 182 has been released by the securement tab 190 and the cavity 154 and medication are accessible, the gap between the first wall 158 and plurality of compartments 40 increase the distance and force necessary to break the seal 54 in the blister pack 20 and sever the perforations 178. The force necessary to dispense the medication is further increased by the puck 100, which introduces added stiffness and rigidity to the assembled container 10. The medication container 10 is thus constructed to prevent children from accessing the medication secured therein and to meet regulatory standards for child-resistant packaging.
The medicine container 10 is assembled using one or more of the following steps. First, the box 150 is prepared and folded. As illustrated in
The box blank is assembled by bending the first section 250 along a point of connection between the first section 250 and the first intermediate section 280. Similarly, the second section 254 is bent along a point of connection between the first intermediate section 280 and the second section 254. In doing so, the first section 250, which forms the first wall 158, is spaced apart from the second section 254, which forms the second wall 162, by the first intermediate section 280, which is one of the intermediate walls 166. The third projection 260c extending from the first section 250 is then secured (i.e., by adhesive or the like) to the second intermediate section 284. The first and second intermediate sections 280, 284 are therefore two of the intermediate walls 166 between the first and second walls 158, 162 of the box blank. When coupled by the intermediate walls 166, the first and second walls 158, 162 are parallel to one another such that the plurality of openings 170 in the first wall 158 are aligned with the plurality of perforations 178 in the second wall 162. The plurality of openings 170 are also complementary to the plurality of perforations 178. The first and second walls 158, 162 also define a portion of the cavity 154 when coupled by two of the four intermediate walls 166.
Prior to being inserted in the cavity 154, the blister pack 20 is applied to the puck such that each of the plurality of compartments of the blister pack 20 is aligned with the plurality of openings 116 in the puck 100. As discussed above, each of the plurality of openings 116 is configured to be complementary to one of the plurality of compartments. Then, together, the blister pack 20 and puck 100 are inserted into the box 150 between the first and second walls 158, 162. The plurality of openings 170 extending through the first wall 158 of the box 150 are aligned with the plurality of perforations 178 in the second wall 162. Each of the plurality of openings 116 of the puck 100 align with the plurality of openings 170 in the first wall 158 and plurality of perforations 178 in the second wall 162. Furthermore, like the openings 116 in the puck 100, each of the aligned plurality of openings 170 in the first wall 158 and plurality of perforations 176 in the second wall 162 are complementary to and aligned with one of the plurality of compartments 40. As such, the medication 42 within the cavity 154 is viewable through the plurality of openings 170 in the first wall 158.
The medicine container assembly 10 is assembled by securing the blister pack 20 and puck 100 within the cavity 154 of the box 150 such that the medication in each of the plurality of compartments 40 is viewable through the plurality of openings 170 in the first wall 158. Accordingly, auxiliary tabs 304 extending from each of the first and second intermediate sections 280, 284 and the first and second projections 260a, 262a, 260b, 260b extending from each of the first and second sections 250, 254 (e.g., first and second walls 158, 162) are folded. As such, the first projections 260, 262a overlap and are secured to the second projections 260b, 262b, which overlap and are secured to the auxiliary projections 304. The walls of the box blank are secured by glue or another suitable adhesive.
The medication information, which might include instructions, dosing information, or information about the medication, is coupled (e.g., by an adhesive) to the first side of the third wall 182. The third wall 182 is then such that the third wall 182 overlays the first wall 158. The securement tab 190 is then coupled to one of the intermediate walls 166 to complete the assembly of the container 10. In the embodiments illustrated in FIGS. 1-37A,B, the blister packs 20, 20a, 20b, the pucks 100, 100a-g, and the box 150 are configured to receive and secure a daily dose of medication. However, in additional or alternative embodiments, the blister packs, the pucks, and the box may be configured to receive and secure hourly, weekly, or monthly medication doses. For example, the box 150′ of
The medicine container assembly 10 may be used to dispense appropriate doses of medication secured therein according to one or more of the following steps. First, the securement tab 190 is released such that the third wall 182 moves from a first, closed position (
As illustrated in
Once the bottom container 10a is removed, an adjacent container 10a′, and therefore all of the other containers 10a′ move downward. The adjacent container 10a′ becomes the bottom container 10a and is disposed within the aperture 416 and is ready to be removed. Once a container 10a is removed, one of the protrusions 424 may be depressed to indicate that container 10a has been removed. For example, the dispenser in the illustrated embodiment is sized and shaped to house seven containers 10 (e.g., a one week's worth of the medication) and the gap includes seven protrusions, one for each day of the week. On a first day of the week (e.g., Monday), the first, bottom container 10 is removed and the first protrusion is depressed. Therefore, the user is alerted to the fact that there should be six containers remaining in the dispenser, which is evident by the through hole in at least one of the first and second side walls or the rear wall and by the six remaining un-depressed protrusions. The dispenser is considered a child-resistant feature because the intended user can modify the amount of containers that are housed in the dispenser compared to the amount of containers that should be in the dispenser.
Thus, the invention provides, among other things, a child-resistant medication container. The invention additionally provides a method of assembling the child-resistant medication container. The invention further provides a method of dispensing medication from a child-resistant medication container. The invention also provides a dispenser for dispensing a plurality of child-resistant medication containers.
Various features and advantages of the invention are set forth in the following claims.
This application is a non-provisional of and claims the benefit of U.S. Provisional Patent Application No. 61/842,841, filed on Jul. 3, 2013, and U.S. Provisional Patent Application No. 61/842,900, filed on Jul. 3, 2013. This application also is a continuation of U.S. Patent Application No. 29/488,207, filed on Apr. 16, 2014, Pat. No. D731783. The entire contents of each application are fully incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
D88285 | Blenker | Nov 1932 | S |
D189489 | Jackson et al. | Dec 1960 | S |
D201899 | Hancock et al. | Aug 1965 | S |
D205676 | Kirwan | Sep 1966 | S |
3288281 | Sparks | Nov 1966 | A |
3305077 | Greif et al. | Feb 1967 | A |
3921804 | Tester | Nov 1975 | A |
RE29705 | Compere | Jul 1978 | E |
4120400 | Kotyuk | Oct 1978 | A |
D254219 | Papciak | Feb 1980 | S |
4192422 | Kotyuk | Mar 1980 | A |
D261198 | Altadonna | Oct 1981 | S |
D263559 | Poore | Mar 1982 | S |
D264538 | Pomroy et al. | May 1982 | S |
4340141 | Fischer | Jul 1982 | A |
D266147 | McIntosh et al. | Sep 1982 | S |
D267767 | Storrs | Feb 1983 | S |
D268130 | Easton | Mar 1983 | S |
D276116 | Basil et al. | Oct 1984 | S |
D293887 | Webster | Jan 1988 | S |
4838444 | Bitel | Jun 1989 | A |
5050739 | Hannan et al. | Sep 1991 | A |
D320930 | Richards | Oct 1991 | S |
D322400 | Sorensen | Dec 1991 | S |
D322934 | Kalvelage | Jan 1992 | S |
5109984 | Romick | May 1992 | A |
D327363 | Farb | Jun 1992 | S |
D331258 | Tarozzi | Nov 1992 | S |
D350478 | Fuller et al. | Sep 1994 | S |
D351995 | Kalvelage | Nov 1994 | S |
D351996 | Kalvelage | Nov 1994 | S |
5489025 | Romick | Feb 1996 | A |
D370414 | Lambelet, Jr. | Jun 1996 | S |
D370625 | Kelsey et al. | Jun 1996 | S |
D372124 | Dammers | Jul 1996 | S |
D372867 | Lambelet, Jr. | Aug 1996 | S |
D382474 | Malmborg | Aug 1997 | S |
5740717 | Sowden et al. | Apr 1998 | A |
D404641 | Kelsey et al. | Jan 1999 | S |
D411445 | Anderson | Jun 1999 | S |
D414106 | Anderson | Sep 1999 | S |
D414409 | Sanfilippo et al. | Sep 1999 | S |
6082544 | Romick | Jul 2000 | A |
6138830 | Muggli | Oct 2000 | A |
D434558 | Brady et al. | Dec 2000 | S |
6273260 | Coldepietro et al. | Aug 2001 | B1 |
D448048 | Brown, III | Sep 2001 | S |
D457246 | Mazel et al. | May 2002 | S |
6443307 | Burridge | Sep 2002 | B1 |
6516949 | Fuller et al. | Feb 2003 | B2 |
6622856 | Gallo et al. | Sep 2003 | B2 |
D480958 | Mazel et al. | Oct 2003 | S |
6659280 | Paliotta et al. | Dec 2003 | B2 |
6679382 | Kancsar et al. | Jan 2004 | B1 |
6793077 | Kancsar et al. | Sep 2004 | B1 |
6896139 | Kancsar et al. | May 2005 | B2 |
6997320 | Kancsar et al. | Feb 2006 | B1 |
D518737 | Zalzal | Apr 2006 | S |
7063211 | Williams-Hartman | Jun 2006 | B2 |
D525777 | Priebe et al. | Aug 2006 | S |
D526478 | Priebe et al. | Aug 2006 | S |
7126879 | Snyder | Oct 2006 | B2 |
7188728 | Williams-Hartman | Mar 2007 | B2 |
D546198 | Currie et al. | Jul 2007 | S |
D558603 | Priebe et al. | Jan 2008 | S |
7360652 | Arnold | Apr 2008 | B2 |
D574665 | James | Aug 2008 | S |
7448496 | Williams-Hartman | Nov 2008 | B2 |
D600503 | Ragsdale et al. | Sep 2009 | S |
7641050 | Klatt et al. | Jan 2010 | B2 |
7665610 | Williams-Hartman | Feb 2010 | B2 |
7696236 | Bradford | Apr 2010 | B2 |
D619257 | Meschenmoser et al. | Jul 2010 | S |
D620260 | Emmert | Jul 2010 | S |
7748535 | Grosskopf | Jul 2010 | B2 |
D622158 | Proulx | Aug 2010 | S |
7767700 | Bradford | Aug 2010 | B2 |
7784250 | Grosskopf | Aug 2010 | B2 |
7900772 | Sack et al. | Mar 2011 | B2 |
7905355 | Williams-Hartman | Mar 2011 | B2 |
7926660 | Jones et al. | Apr 2011 | B2 |
D637391 | Stevens et al. | May 2011 | S |
7967144 | Sack et al. | Jun 2011 | B2 |
D642789 | Cooper | Aug 2011 | S |
7997411 | Williams-Hartman | Aug 2011 | B2 |
D650295 | Schmitz et al. | Dec 2011 | S |
8132671 | Hession | Mar 2012 | B2 |
D658991 | Schmitz et al. | May 2012 | S |
D659019 | Specker et al. | May 2012 | S |
D659550 | Mazor | May 2012 | S |
8205752 | Sack et al. | Jun 2012 | B2 |
D663981 | Purcell | Jul 2012 | S |
D669311 | Hsu | Oct 2012 | S |
D670178 | Carson | Nov 2012 | S |
D673297 | Hawker | Dec 2012 | S |
8342330 | Weston et al. | Jan 2013 | B2 |
8342331 | Ziemba et al. | Jan 2013 | B2 |
8403212 | van Esch | Mar 2013 | B2 |
8413813 | Grosskopf | Apr 2013 | B2 |
8420674 | Bradford | Apr 2013 | B2 |
D683950 | Ernster et al. | Jun 2013 | S |
D684482 | Stevens | Jun 2013 | S |
D685272 | Stevens | Jul 2013 | S |
8479921 | Ingraham | Jul 2013 | B2 |
D688570 | Logue | Aug 2013 | S |
D688571 | Logue | Aug 2013 | S |
8499531 | Benetti et al. | Aug 2013 | B2 |
D689373 | Logue | Sep 2013 | S |
D689374 | Logue | Sep 2013 | S |
D689778 | Logue | Sep 2013 | S |
D691465 | O'Brien et al. | Oct 2013 | S |
D691856 | Dabney-Wiggs | Oct 2013 | S |
8544650 | Williams-Hartman | Oct 2013 | B2 |
8550248 | Busen | Oct 2013 | B1 |
8556077 | Hanley | Oct 2013 | B1 |
8561798 | Hession | Oct 2013 | B2 |
8567606 | Bellamah et al. | Oct 2013 | B2 |
8573403 | Stevens et al. | Nov 2013 | B2 |
8579106 | Naik et al. | Nov 2013 | B2 |
8584857 | Ozawa et al. | Nov 2013 | B2 |
D694904 | Banes et al. | Dec 2013 | S |
8602218 | Grosskopf | Dec 2013 | B2 |
8607982 | Jones | Dec 2013 | B2 |
8607983 | Niven et al. | Dec 2013 | B2 |
D697095 | Chan | Jan 2014 | S |
8627957 | Ziemba et al. | Jan 2014 | B2 |
8640917 | Kracke | Feb 2014 | B2 |
8672134 | Sprada et al. | Mar 2014 | B2 |
8740003 | Elliott | Jun 2014 | B2 |
8746454 | Doucet et al. | Jun 2014 | B2 |
8752704 | Leon Alonso et al. | Jun 2014 | B2 |
8757381 | Bouthiette | Jun 2014 | B2 |
D708760 | Smeja | Jul 2014 | S |
D708761 | Smeja | Jul 2014 | S |
D708762 | Smeja | Jul 2014 | S |
D711219 | Palsson | Aug 2014 | S |
D713051 | Smeja | Sep 2014 | S |
D723279 | Wax | Mar 2015 | S |
20030034271 | Burridge | Feb 2003 | A1 |
20030042167 | Balz | Mar 2003 | A1 |
20030164380 | Taneja et al. | Sep 2003 | A1 |
20060163110 | Adler | Jul 2006 | A1 |
20070185615 | Bossi et al. | Aug 2007 | A1 |
20090038982 | Doucet et al. | Feb 2009 | A1 |
20090242451 | Kessler | Oct 2009 | A1 |
20090301924 | Rondeau | Dec 2009 | A1 |
20110215022 | Sack et al. | Sep 2011 | A1 |
20120248005 | Bergey | Oct 2012 | A1 |
20120261275 | Intini | Oct 2012 | A1 |
20130008825 | McArthur et al. | Jan 2013 | A1 |
20130193029 | Weston et al. | Aug 2013 | A1 |
20130220870 | Grosskopf | Aug 2013 | A1 |
20130220871 | Bradford | Aug 2013 | A1 |
20130233756 | Weston et al. | Sep 2013 | A1 |
20130256183 | Ingraham | Oct 2013 | A1 |
20130281960 | Hanley | Oct 2013 | A1 |
20130306511 | Branyon et al. | Nov 2013 | A1 |
20140001194 | Pipes et al. | Jan 2014 | A1 |
20140027340 | Hession | Jan 2014 | A1 |
20140027341 | Ludwig et al. | Jan 2014 | A1 |
20140083900 | Ziemba et al. | Mar 2014 | A1 |
20140171436 | Kamen et al. | Jun 2014 | A1 |
20140183095 | Choubey et al. | Jul 2014 | A1 |
20140209498 | Stevens | Jul 2014 | A1 |
20140214438 | Ahmadi | Jul 2014 | A1 |
20140216968 | Wagner et al. | Aug 2014 | A1 |
20140216977 | Bowers et al. | Aug 2014 | A1 |
Number | Date | Country |
---|---|---|
314244 | May 2007 | AU |
341384 | Mar 2012 | AU |
346153 | Jan 2013 | AU |
348282 | May 2013 | AU |
357121 | Aug 2014 | AU |
359486 | Dec 2014 | AU |
114356 | Mar 2008 | CA |
120646 | Mar 2014 | CA |
36012012 | Dec 2012 | CL |
8902013 | Apr 2013 | CL |
8912013 | Apr 2013 | CL |
1211191 | May 2002 | EP |
1481914 | Dec 2004 | EP |
2005120984 | Dec 2005 | WO |
2010015638 | Feb 2010 | WO |
2014057967 | Apr 2014 | WO |
2014085625 | Jun 2014 | WO |
Entry |
---|
Japanese Office action for Design Application No. 2014-7622 dated Apr. 22, 2014. (1 page). |
Japanese Office action for Design Application No. 2014-7623 dated Apr. 22, 2014. (1 page). |
International Search Report and Written Opinion for Application No. PCT/US2014/045459, mailed on Nov. 3, 2014, 18 pages. |
U.S. Appl. No. 29/424,276, filed Jun. 10, 2012, Akana et al. |
Chilean Patent Office Action for Application No. 2014-000864 dated Sep. 21, 2015 (8 pages). |
Chilean Patent Office Action for Application No. 2014-000866 dated Sep. 21, 2015 (8 pages). |
Chilean Patent Office Action for Application No. 2014-002839 dated Sep. 28, 2015 (6 pages). |
Number | Date | Country | |
---|---|---|---|
20150014203 A1 | Jan 2015 | US |
Number | Date | Country | |
---|---|---|---|
61842841 | Jul 2013 | US | |
61842900 | Jul 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 29488207 | Apr 2014 | US |
Child | 14323701 | US |